BWM
LLY icon

Baystate Wealth Management’s Eli Lilly LLY Stock Holding History

Baystate Wealth Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$1.11M Buy
1,898
+945
+99% +$552K 0.08% 86
2023
Q3 		$512K Buy
953
+197
+26% +$102K 0.04% 131
2023
Q2 		$355K Buy
756
+282
+59% +$118K 0.03% 153
2023
Q1 		$163K Buy
474
+8
+2% +$2.7K 0.01% 200
2022
Q4 		$171K Buy
466
+1
+0.2% +$355 0.02% 197
2022
Q3 		$150K Buy
465
+2
+0.4% +$634 0.02% 196
2022
Q2 		$150K Buy
463
+1
+0.2% +$300 0.01% 199
2022
Q1 		$132K Buy
462
+2
+0.4% +$515 0.01% 212
2021
Q4 		$127K Sell
460
-5
-1% -$1.27K 0.01% 220
2021
Q3 		$108K Buy
465
+8
+2% +$1.97K 0.01% 208
2021
Q2 		$105K Buy
457
+39
+9% +$7.83K 0.01% 203
2021
Q1 		$78K Buy
418
+2
+0.5% +$391 0.01% 218
2020
Q4 		$70K Buy
416
+1
+0.2% +$149 0.01% 216
2020
Q3 		$61K Buy
415
+3
+0.7% +$464 0.01% 201
2020
Q2 		$68K Buy
412
+250
+154% +$38.4K 0.01% 196
2020
Q1 		$22K Buy
162
+1
+0.6% +$137 ﹤0.01% 272
2019
Q4 		$21K Buy
161
+47
+41% +$5.45K ﹤0.01% 317
2019
Q3 		$13K Buy
114
+65
+133% +$7.24K ﹤0.01% 336
2019
Q2 		$6K Sell
49
-57
-54% -$6.71K ﹤0.01% 409
2019
Q1 		$13K Buy
106
+32
+43% +$3.89K ﹤0.01% 354
2018
Q4 		$9K Sell
74
-27
-27% -$3.02K ﹤0.01% 386
2018
Q3 		$11K Hold
101
– – ﹤0.01% 368
2018
Q2 		$9K Sell
101
-75
-43% -$6.16K ﹤0.01% 388
2018
Q1 		$14K Sell
176
-1,394
-89% -$112K ﹤0.01% 327
2017
Q4 		$134K Sell
1,570
-69
-4% -$5.87K 0.02% 107
2017
Q3 		$143K Sell
1,639
-7
-0.4% -$574 0.02% 96
2017
Q2 		$138K Sell
1,646
-38
-2% -$3.1K 0.02% 96
2017
Q1 		$145K Sell
1,684
-54
-3% -$4.33K 0.03% 98
2016
Q4 		$130K Buy
+1,738
New +$129K 0.03% 92

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Baystate Wealth Management's LLY Position: Q4 2023 in Review

Baystate Wealth Management increased its Eli Lilly (LLY) stake by 99% in Q4 2023, buying an estimated $552K and bringing the position to 1,898 shares worth $1.11M. The position accounts for 0.08% of the portfolio, ranked #86.

Baystate Wealth Management first reported a position in LLY in Q4 2016 and has held it in 29 quarters since. 3,272 funds tracked by Wall St. Rank hold LLY as of Q4 2023.

  • Baystate Wealth Management held 1,898 shares of Eli Lilly worth $1.11M as of Q4 2023.
  • Baystate Wealth Management bought 945 Eli Lilly shares in Q4 2023, an estimated $552K.
  • Eli Lilly made up 0.08% of Baystate Wealth Management's portfolio in Q4 2023, its #86 holding.
  • Baystate Wealth Management first reported a position in Eli Lilly in Q4 2016 and has held it in 29 quarters since.
  • 3,272 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2023.

Based on Baystate Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.